FDA's can­cer chief weighs in on com­mon chemo short­ages — re­port

Richard Paz­dur, di­rec­tor of the FDA’s On­col­o­gy Cen­ter of Ex­cel­lence, at­trib­ut­es the cur­rent short­age of two can­cer drugs to drug com­pa­nies that haven’t in­vest­ed in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER